Astellas Pharma (YPH) Q3 2025 Earnings Report
DE:YPH Q3 2025 EPS Results
- Actual EPS
- EUR 0.32
- Consensus EPS
- EUR 0.26
- Beat/Miss
- Beat by +EUR 0.06
- One Year Ago EPS
- -EUR 0.31
DE:YPH Q3 2025 Revenue Results
- Actual Revenue
- EUR 3.23B
- Expected Revenue
- EUR 3.00B
- Beat/Miss
- Beat by +EUR 234.03M
- YoY Revenue Growth
- +10.40%
Earnings Announcement Details
- Quarter
- Q3 2025
- Date
- 02/04/2026
- Time
- Before Open
- Conference Call
- Wednesday, February 4, 2026
DE:YPH Upcoming Earnings
Astellas Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.
Q3 2025 Earnings Call Audio
DE:YPH Q3 2025 Earnings Call
0:00 / 0:00
Q3 2025 Earnings Slide Deck
Q3 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:YPH Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 04, 2026 | 2026 (Q2) | 0.37- | 0.25 | ― | ― |
| Aug 05, 2026 | 2026 (Q1) | 0.310.45 | 0.22 | 107.09% (+0.23) | |
| Apr 27, 2026 | 2025 (Q4) | 0.170.14 | 0.24 | -41.95% (-0.10) | |
| Feb 04, 2026 | 2025 (Q3) | 0.260.32 | -0.31 | 202.73% (+0.63) | |
| Oct 30, 2025 | 2025 (Q2) | 0.170.25 | 0.11 | 120.44% (+0.14) | |
| Jul 30, 2025 | 2025 (Q1) | 0.110.22 | 0.12 | 82.00% (+0.10) | |
| Apr 25, 2025 | 2024 (Q4) | 0.120.24 | -0.11 | 325.50% (+0.34) | |
| Feb 04, 2025 | 2024 (Q3) | 0.14-0.31 | 0.06 | -624.52% (-0.37) | |
| Oct 30, 2024 | 2024 (Q2) | 0.100.11 | 0 | 2607.50% (+0.12) | |
| Aug 01, 2024 | 2024 (Q1) | 0.050.12 | 0.1 | 13.76% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
